MARKET

AZN

AZN

AstraZeneca
NYSE
156.45
-0.79
-0.50%
After Hours: 156.50 +0.05 +0.03% 19:51 08/14 EDT
OPEN
155.50
PREV CLOSE
157.24
HIGH
156.46
LOW
154.53
VOLUME
3.70M
TURNOVER
--
52 WEEK HIGH
209.46
52 WEEK LOW
150.05
MARKET CAP
242.66B
P/E (TTM)
23.39
1D
5D
1M
3M
1Y
5Y
1D
Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?
The Motley Fool · 1d ago
Roche Is Getting More Benefit Of The Doubt On Improving Execution
Seeking Alpha · 1d ago
AstraZeneca’s STEP Asthma Trial Completion: What It Could Mean for AZN Investors
TipRanks · 1d ago
U.K. regulator reaffirms safety of childhood vaccination
Seeking Alpha · 2d ago
Investor backlash killed AstraZeneca, Bristol Myers tie-up, FT reports
TipRanks · 3d ago
AstraZeneca held talks with Bristol-Myers through spring, summer - FT
Seeking Alpha · 3d ago
Trump Trade: President signs EO to split up of childhood vaccines
TipRanks · 3d ago
Polen International Equity adds NOK, MUFG; exits AIVAF, RNMBF among Q2 moves
Seeking Alpha · 3d ago
More
About AZN
AstraZeneca PLC is a United Kingdom-based science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines. The Company operates across therapy areas, including Oncology; Cardiovascular, Renal and Metabolism (CVRM); Respiratory and Immunology (R&I); Vaccines and Immune Therapies (V&I), and Rare Disease. In the Oncology area, its key products include Tagrisso, Imfinzi, Calquence, Lynparza, and Enhertu. The key products of CVRM area include Farxiga/Forxiga, Brilinta/Brilique, Crestor, and Lokelma. In the R&I area, the key products are Symbicort, Fasenra, Breztri/Trixeo, and Tezspire. In the V&I Therapies area, the products are Beyfortus and FluMist. The products in the Rare Disease area are Ultomiris, Soliris, Strensiq, and Koselugo. It has about 191 projects in its development pipeline, including 19 new molecular entities (NMEs) in the late-stage pipeline. The Company distributes its products in over 125 countries.

Webull offers AstraZeneca PLC (US) stock information, including NYSE: AZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AZN stock methods without spending real money on the virtual paper trading platform.